Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for c…
This bill amends the Social Security Act to require that any advertisement for a Medicare Advantage (MA) plan include, beginning one year after enactment and using the most recent completed plan year, verbal and visual disclosures of: (A) the number of prior authorization requests denied (including those later reconsidered and approved); (B) the number of those denials that were later reconsidered and approved; and (C) the average number of days between an initial denial and a later approval for those reconsidered-and-approved requests. The requirement applies to information from the most recent plan year ending before the advertisement is disseminated.
Whether the requirement is primarily a pro-consumer transparency win (liberal/centrist) or an unnecessary regulatory burden (conservative).
Relative to its intended legislative type, this bill establishes a clear, narrowly focused legal obligation on Medicare Advantage plan advertising to disclose specific prior-authorization denial-related metrics.
This bill amends the Social Security Act to require that any advertisement for a Medicare Advantage (MA) plan include, beginning one year after enactment and using the most recent completed plan year, verbal and visual disclosures of: (A) the number of prior authorization requests denied (including those later reconsidered and approved); (B) the number of those denials that were later reconsidered and approved; and (C) the average number of days between an initial denial and a later approval for those reconsidered-and-approved requests.
The requirement applies to information from the most recent plan year ending before the advertisement is disseminated.
The disclosure must be both verbal and visual to the extent possible.
Content-wise the bill is narrow, administratively focused, and aimed at increasing transparency — attributes that improve legislative prospects relative to large entitlement changes. However, it creates recurring compliance obligations for a well-organized private sector (MA plans) that has historically resisted new federal mandates; it lacks built-in compromise features beyond a one-year delay and does not create incentives or offsets that might reduce opposition. Thus, while passage is plausible—especially as part of a larger package or if insurer resistance is muted—it is not highly likely on the merits alone.
Relative to its intended legislative type, this bill establishes a clear, narrowly focused legal obligation on Medicare Advantage plan advertising to disclose specific prior-authorization denial-related metrics. It specifies the required data elements and an effective date but leaves many implementation details unspecified.
Whether the requirement is primarily a pro-consumer transparency win (liberal/centrist) or an unnecessary regulatory burden (conservative).
These are examples from the analysis, not a ranked list of the most-affected groups.
Whether the requirement is primarily a pro-consumer transparency win (liberal/centrist) or an unnecessary regulatory burden (conservative).
A liberal/left-leaning observer would view this bill as a pro-consumer transparency measure that shines light on how often MA plans deny care and how long beneficiaries may wait for reversals.
They would likely welcome the basic reporting as a step toward accountability for insurers that manage Medicare benefits.
However, they would note the bill is limited because it reports counts and an average delay but does not require rates, breakdowns by service, patient harm/outcomes, or easy-to-compare standardized metrics.
A centrist/moderate would generally view this as a reasonable, targeted transparency requirement that improves consumer information without dramatically reshaping the Medicare Advantage program.
They would appreciate the modest, specific nature of the change but have practical concerns about implementation details that could create confusion or administrative burden.
A centrist would look for clear CMS guidance on definitions, standardized presentation, and assurances that the requirement does not impose large compliance costs that reduce plan benefits or increase program costs.
A mainstream conservative perspective would be skeptical of adding another federally mandated disclosure rule for private Medicare Advantage plans, viewing it as additional regulatory burden that could raise administrative costs.
They might accept the value of transparency in principle but question whether the federal government should dictate advertising content and metrics, especially when the bill does not require comparable disclosures by traditional Medicare.
Concerns about increased costs, potential chilling of marketing, and federal overreach into plan operations would predominate.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Content-wise the bill is narrow, administratively focused, and aimed at increasing transparency — attributes that improve legislative prospects relative to large entitlement changes. However, it creates recurring compliance obligations for a well-organized private sector (MA plans) that has historically resisted new federal mandates; it lacks built-in compromise features beyond a one-year delay and does not create incentives or offsets that might reduce opposition. Thus, while passage is plausible—especially as part of a larger package or if insurer resistance is muted—it is not highly likely on the merits alone.
The bill has not accumulated any surfaced votes yet.
Whether the requirement is primarily a pro-consumer transparency win (liberal/centrist) or an unnecessary regulatory burden (conservative).
Content-wise the bill is narrow, administratively focused, and aimed at increasing transparency — attributes that improve legislative prosp…
Relative to its intended legislative type, this bill establishes a clear, narrowly focused legal obligation on Medicare Advantage plan advertising to disclose specific prior-authorization denial-related metrics. It spec…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.